Cardlytics (CDLX) IPO Opens 7% Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Cardlytics (Nasdaq: CDLX) to Ring The Nasdaq Stock Market Opening Bell in Celebration of its IPO
February 9, 2018 6:00 AM ESTADVISORY, Feb. 09, 2018 (GLOBE NEWSWIRE) --
What:Â Cardlytics (Nasdaq: CDLX), a purchase intelligence platform that helps make marketing more relevant and measurable, will visit the Nasdaq MarketSite in Times Square, in celebration of its initial public offering (IPO).
In honor of the occasion, Scott Grimes, CEO & Co-Founder & Lynne Laube, COO & Co-Founder, will ring the Opening Bell.Â
Where:Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:Friday, February 9, 2018 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â
Cardlytics Media... More
Cardlytics Announces Pricing of Initial Public Offering
February 8, 2018 6:41 PM ESTATLANTA, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cardlytics, Inc., a purchase intelligence platform that helps make marketing more relevant and measurable, today announced the pricing of its initial public offering of 5,400,000 shares of common stock at a price to the public of $13.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Cardlytics. In addition, Cardlytics has granted the underwriters a 30-day option to purchase up to an additional 810,000 shares of common stock. Cardlytics common stock is expected to begin trading on the Nasdaq Global Market under the ticker symbol CDLX on February 9, 2018. The... More
